Genetic mouse models of Alzheimer's disease

Neural Plasticity

Volumn 12, Issue 4, 2005, Pages 299-310

  Mineur, Yann S ^a   McLoughlin, Declan ^b   Crusio, Wim E ^c   Sluyter, Frans ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Lab Neurosci Comportementales/C   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; DNA; GAMMA SECRETASE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL MODEL; DNA MODIFICATION; GENE FUNCTION; GENE MUTATION; GENETIC MODEL; KNOCKOUT MOUSE; MEDICAL LITERATURE; MOUSE; MOUSE STRAIN; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; RELIABILITY; REPRODUCIBILITY; REVIEW; TRANSGENIC MOUSE; TREATMENT PLANNING; VALIDITY;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; ENDOPEPTIDASES; HUMANS; MICE; MICE, TRANSGENIC; TAU PROTEINS;

EID: 30444445235     PISSN: 20905904     EISSN: None     Source Type: Journal    
DOI: 10.1155/NP.2005.299     Document Type: Review

References (54)

1. Bergem AL, Engedal K, Kringlen E. 1997. The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch Gen Psychiatry 543: 264-270.
2. Billings LM, Oddo S, Green KN, McGaugh JL, Laferla FM. 2005. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 455: 675-688.
3. Boomsma D, Busjahn A, Peltonen L. 2002. Classical twin studies and beyond. Nat Rev Genet 311: 872-882.
4. Brandt R, Hundelt M, Shahani N. 2005. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim Biophys Acta 1739: 331-354.
5. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, et al. 1998. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273: 27765-27767.
6. Cao X, Sudhof TC. 2001. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293(5527): 115-120.
7. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. 2005. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 81: 79-84.
8. Corcoran KA, Lu Y, Turner RS, Maren S. 2002. Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learn Mem 95: 243-252.
9. Crabbe JC, Wahlsten D, Dudek BC. 1999. Genetics of mouse behavior: interactions with laboratory environment. Science 284(5420): 1670-1672.
10. De Strooper B, Woodgett J. 2003. Alzheimer's disease: Mental plaque removal. Nature 423(6938): 392-393.
11. Dewachter I, Reverse D, Caluwaerts N, Ris L, Kuiperi C, Van den Haute C, et al. 2002. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 229: 3445-3453.
12. Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, et al. 2002. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cel 131: 85-97.
13. Glenner GG, Wong CW. 1984a. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122: 1131-1135.
14. Glenner GG, Wong CW. 1984b. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890.
15. Glenner GG, Wong CW, Quaranta V, Eanes ED. 1984. The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. Appl Pathol 26: 357-369.
16. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349(6311): 704-706.
17. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580): 353-356.
18. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. 2003. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 608: 1119-1122.
19. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274(5284): 99-102.
20. Hu ZH, Wang XC, Li LY, Liu ML, Liu R, Ling Z, et al. 2004. Correlation of behavior changes and BOLD signal in Alzheimer-like rat model. Acta Biochim Biophys Sin Shanghai 36: 803-810.
21. Huang XG, Yee BK, Nag S, Chan ST, Tang F. 2003. Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235. Exp Neurol 183: 673-681.
22. Ingram EM, Spillantini MG. 2002. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol Med 8: 555-562.
23. Jankowsky, JL, Xu, G, Fromholt, D, Gonzales, V, Borchelt, DR. 2003. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 62: 1220-1227.
24. Janus C, D'Amelio S, Amitay O, Chishti MA, Strome R, Fraser P, et al. 2000. Spatial learning in transgenic mice expressing human presenilin 1 PS1. transgenes. Neurobiol Aging 214: 541-549.
25. Karkkainen I, Rybnikova E, Pelto-Huikko M, Huovila AP. 2000. Metalloprotease-disintegrin ADAM genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci 156: 547-60.
26. Katsel PL, Davis KL, Haroutunian V. 2005. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 63, 41-82.
27. Kobayashi DT, Chen KS. 2005. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav 43: 173-196.
28. Laferla, FM, Oddo, S. 2005. Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 114: 170-176.
29. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, et al. 1999. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 67: 3922-3927.
30. Lazarov, O, Robinson, J, Tang, YP, Hairston, IS, Korade-Mirnics, Z, Lee, VM, et al. 2005. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 1205: 701-713.
31. Lee B, English JA, Paul IA. 2000. LP-BM5 infection impairs spatial working memory in C57BL/6 mice in the Morris water maze. Brain Res 856: 129-134.
32. Lee VM, Kenyon TK, Trojanowski JQ. 2005. Transgenic animal models of tauopathies. Biochim Biophys Acta 1739: 251-259.
33. Link CD. 2005. Invertebrate models of Alzheimer's disease. Genes Brain Behav 43: 147-156.
34. Lovestone S, McLoughlin DM. 2002. Protein aggregates and dementia: is there a common toxicity? J Neurol Neurosurg Psychiatry 722: 152-161.
35. Marchesi VT. 2005. An alternative interpretation of the amyloid A {beta} hypothesis with regard to the pathogenesis of Alzheimer's disease. Proc Natl Acad Sci USA. 102: 9093-9098.
36. Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F. 1996. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 156: 1265-1274.
37. Moechars D, Lorent K, Van Leuven F. 1999. Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience 913: 819-830.
38. Naslund J, Jensen M, Tjernberg LO, Thyberg J, Terenius L, Nordstedt C. 1994. The metabolic pathway generating p3, an A beta-peptide fragment, is probably non-amyloidogenic. Biochem Biophys Res Commun 2042: 780-787.
39. Pompl PN, Mullan MJ, Bjugstad K, Arendash GW. 1999. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW): transgenic mouse model for Alheimer's disease. J Neurosci Methods 871: 87-95.
40. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, et al. 2004, A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113: 1456-1464.
41. Raiha I, Kaprio J, Koskenvuo M, Rajala T, Sourander L. 1996. Alzheimer's disease in Finnish twins. Lancet 347(9001): 573-578.
42. Selkoe DJ. 2004. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 611: 1054-1061.
43. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. 1997. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 894: 629-639.
44. Stephan A, Phillips AG. 2005. A case for a non-transgenic animal model of Alzheimer's disease. Genes Brain Behav 43: 157-172.
45. Stoothoff WH, Johnson GV. 2005. Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta 1739: 280-297.
46. Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, et al. 2002. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 221: 133-141.
47. Tanzi RE, Bertram L. 2005. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 1204: 545-555.
48. Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, Iwasaki K, et al. 2002. Tau filament formation and associative memory deficit in aged mice expressing mutant R406W. human tau. Proc Natl Acad Sci USA 99: 13896-13901.
49. Walsh DM, Selkoe DJ. 2004. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 441: 181-193.
50. Wei Q, Holzer M, Brueckner MK, Liu Y, Arendt T. 2002. Dephosphorylation of tau protein by calcineurin triturated into neural living cells. Cell Mol Neurobiol 221: 13-24.
51. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, et al. 2002. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 225: 1858-1867.
52. Wilquet V, De Strooper B. 2004. Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 145: 582-588.
53. World Health Organization. 2000. The World Health Report 2000 - Health Systems: Improving Performance. Geneva, Switzerland: WHO.
54. Yu H, Saura CA, Choi SY, Sun LD, Yang X, Handler M, et al. 2001. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron 315: 713-726.